| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327470 | Gynecologic Oncology | 2005 | 8 Pages |
Abstract
These HPV tests have the potential to improve the detection rate of high-grade cervical neoplasia, with some limitations. The mRNA test seems to be more appropriate for risk-evaluation. Larger scale, population based studies are necessary to evaluate the predictive values of HPV testing in Norway.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
A.K. Lie, B. Risberg, B. Borge, B. Sandstad, J. Delabie, R. Rimala, M. Onsrud, S. Thoresen,